West Virginia · 2026 Regular Session · Bill
HB 4626: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
Vetoed Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Vetoed
Last official action: ·Record last updated:
Plain-language summary
HB 4626 is a bill introduced in the West Virginia House on January 21, 2026. According to its official title, it concerns: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine. Primary sponsor: Ryan Browning (Republican). It lists 6 additional sponsors. Most recent recorded action (April 2, 2026): Vetoed by Governor 4/1/2026.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 7
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Ryan Browning | Primary sponsor | Republican | House | 28 |
| Adam Burkhammer | Co-sponsor | Republican | House | 64 |
| Mark Dean | Co-sponsor | Republican | House | 34 |
| Scot Heckert | Co-sponsor | Republican | House | 13 |
| Rick Hillenbrand | Co-sponsor | Republican | House | 88 |
| Mike Hite | Co-sponsor | Republican | House | 92 |
| Evan Worrell | Co-sponsor | Republican | House | 23 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Vetoed by Governor 4/1/2026
- To Governor 3/31/2026
- Vetoed by Governor 4/1/2026 - House Journal
- Vetoed by Governor 4/1/2026 - Senate Journal
- To Governor 3/31/2026 - Senate Journal
- House received Senate message
- Completed legislative action
- Communicated to House
- Passed Senate (Roll No. 487)
- Read 3rd time
- On 3rd reading
- Read 2nd time
Showing 12 most recent of 36 actions. Full history